Insider Trading & Ownership - Parschauer Karah Herdman

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Parschauer Karah Herdman
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-06-12
Sale
2024-06-12
7:47 pm
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and Chief Legal Officer
9,806$45$441,27057,981
(Direct)
View
2024-03-01
Sale
2024-03-05
8:22 pm
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and Chief Legal Officer
3,756$53.76$201,92398,740
(Direct)
View
2024-01-30
Sale
2024-02-02
4:57 pm
Evolus Inc.EOLSParschauer Karah Herdman
Director
11,931$13.14$156,73331,243
(Direct)
View
2023-05-04
Sale
2023-05-05
2:16 pm
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and Chief Legal Officer
4,378$45$197,01051,982
(Direct)
View
2023-03-01
Sale
2023-03-03
7:59 pm
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and Chief Legal Officer
3,161$45.25$143,03595,539
(Direct)
View
2022-03-07
Sale
2022-03-08
12:25 pm
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and Chief Legal Officer
5,140$62.95$323,56334,438
(Direct)
View
2022-03-01
Sale
2022-03-03
6:08 pm
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and Chief Legal Officer
2,886$66.62$192,26564,478
(Direct)
View
2021-10-14
Sale
2021-10-18
6:46 pm
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
310$81.14$25,15328,358
(Direct)
View
2021-09-08
Sale
2021-09-09
6:22 pm
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
7,336$100.65$738,36846,332
(Direct)
View
2021-06-10
Sale
2021-06-11
9:08 pm
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
1,329$100$132,90028,668
(Direct)
View
2021-05-06
Sale
2021-05-10
6:13 pm
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
313$113.67$35,57929,997
(Direct)
View
2021-03-01
Sale
2021-03-03
8:47 pm
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
3,970$138.17$548,53541,227
(Direct)
View
2020-10-30
Sale
2020-11-02
5:05 pm
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
9,903$100.12$991,48849,061
(Direct)
View
2020-10-28
Sale
2020-10-30
5:28 pm
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
97$100$9,70058,871
(Direct)
View
2020-10-14
Sale
2020-10-16
7:21 pm
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
325$88$28,60023,968
(Direct)
View
2020-10-08
Sale
2020-10-13
5:53 pm
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
10,000$95$950,00059,293
(Direct)
View
2020-10-06
Sale
2020-10-07
2:57 pm
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
10,000$90$900,00041,293
(Direct)
View
2020-09-23
Sale
2020-09-24
4:47 pm
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
10,000$85$850,00051,293
(Direct)
View
2020-08-17
Sale
2020-08-19
2:12 pm
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
12,370$88.43$1,093,88469,293
(Direct)
View
2020-05-18
Sale
2020-05-19
7:12 pm
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
2,722$74.72$203,37427,312
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-10-18
Option Award
2024-10-21
8:39 pm
2025-05-31
2034-10-17
Tenaya Therapeutics Inc.TNYAParschauer Karah Herdman
Director
34,000$034,000
(Direct)
View
2024-03-01
Option Award
2024-03-05
8:22 pm
N/A
2034-03-01
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and Chief Legal Officer
50,157$098,740
(Direct)
View
2024-02-07
Option Award
2024-02-09
6:37 pm
N/A
2034-02-07
Evolus Inc.EOLSParschauer Karah Herdman
Director
15,841$047,084
(Direct)
View
2023-06-09
Option Award
2023-06-12
8:24 pm
2024-06-09
2033-06-08
Tenaya Therapeutics Inc.TNYAParschauer Karah Herdman
Director
29,532$029,532
(Direct)
View
2023-03-01
Option Award
2023-03-03
7:59 pm
N/A
2033-03-01
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and Chief Legal Officer
64,063$095,539
(Direct)
View
2023-01-27
Option Award
2023-01-31
8:41 pm
N/A
2033-01-27
Evolus Inc.EOLSParschauer Karah Herdman
Director
20,082$054,963
(Direct)
View
2022-04-21
Option Award
2022-10-03
7:56 pm
N/A
2027-02-28
Anebulo Pharmaceuticals Inc.ANEBParschauer Karah Herdman
Director
30,425$030,425
(Direct)
View
2022-09-08
Option Award
2022-09-09
7:25 pm
2023-09-08
2032-09-07
Tenaya Therapeutics Inc.TNYAParschauer Karah Herdman
Director
20,000$020,000
(Direct)
View
2022-03-01
Option Award
2022-03-03
6:08 pm
N/A
2032-03-01
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and Chief Legal Officer
38,900$064,478
(Direct)
View
2022-01-24
Option Award
2022-01-26
9:01 pm
N/A
2032-01-24
Evolus Inc.EOLSParschauer Karah Herdman
Director
38,295$057,608
(Direct)
View
2021-12-22
Option Award
2021-12-23
5:58 pm
N/A
2031-12-22
Tenaya Therapeutics Inc.TNYAParschauer Karah Herdman
Director
19,495$019,495
(Direct)
View
2021-09-08
Exercise
2021-09-09
6:22 pm
N/A
2026-06-20
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
7,336$046,332
(Direct)
View
2021-09-08
Exercise
2021-09-09
6:22 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
7,336$54.546,332
(Direct)
View
2021-06-18
Option Award
2021-06-22
6:33 pm
N/A
2031-06-18
Arcturus Therapeutics Holdings Inc.ARCTParschauer Karah Herdman
Director
15,000$015,000
(Direct)
View

Ownership
2021-05-06
8:47 pm
N/A
N/A
Anebulo Pharmaceuticals Inc.ANEBParschauer Karah Herdman
Director
0$082,290
(Direct)
View
2021-03-01
Option Award
2021-03-03
8:47 pm
N/A
2031-03-01
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
21,136$041,227
(Direct)
View
2021-02-05
Option Award
2021-02-09
5:12 pm
N/A
N/A
Evolus Inc.EOLSParschauer Karah Herdman
Director
19,313$019,313
(Direct)
View
2020-10-30
Exercise
2020-11-02
5:05 pm
N/A
2026-06-20
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
9,903$049,061
(Direct)
View
2020-10-30
Exercise
2020-11-02
5:05 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
9,903$54.549,061
(Direct)
View
2020-10-28
Exercise
2020-10-30
5:28 pm
N/A
2026-06-20
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
97$058,871
(Direct)
View
2020-10-28
Exercise
2020-10-30
5:28 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
97$54.558,871
(Direct)
View
2020-10-08
Exercise
2020-10-13
5:53 pm
N/A
2026-06-20
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
10,000$059,293
(Direct)
View
2020-10-08
Exercise
2020-10-13
5:53 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
10,000$54.559,293
(Direct)
View
2020-10-06
Exercise
2020-10-07
2:57 pm
N/A
2028-03-01
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
10,000$041,293
(Direct)
View
2020-10-06
Exercise
2020-10-07
2:57 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
10,000$48.4341,293
(Direct)
View
2020-09-23
Exercise
2020-09-24
4:47 pm
N/A
2028-03-01
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
10,000$051,293
(Direct)
View
2020-09-23
Exercise
2020-09-24
4:47 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
10,000$48.4351,293
(Direct)
View
2020-08-17
Exercise
2020-08-19
2:12 pm
N/A
2026-06-20
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
10,000$069,293
(Direct)
View
2020-08-17
Exercise
2020-08-19
2:12 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
10,000$54.569,293
(Direct)
View
2020-06-22
Option Award
2020-06-24
8:02 pm
N/A
2030-06-21
Arcturus Therapeutics Holdings Inc.ARCTParschauer Karah Herdman
Director
15,000$015,000
(Direct)
View
2020-06-20
Tax Withholding
2020-06-22
1:46 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
649$78.2226,663
(Direct)
View
2020-05-06
Tax Withholding
2020-05-08
8:02 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
248$66.2629,904
(Direct)
View
2020-04-19
Tax Withholding
2020-04-21
3:36 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
248$58.5730,152
(Direct)
View
2020-03-01
Tax Withholding
2020-03-03
8:00 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
2,118$56.0852,400
(Direct)
View
2020-03-01
Option Award
2020-03-03
8:00 pm
N/A
2030-03-01
Ultragenyx Pharmaceutical Inc.RAREParschauer Karah Herdman
EVP and General Counsel
35,434$052,400
(Direct)
View
2020-01-23
Option Award
2020-01-24
9:06 pm
N/A
2030-01-23
Evolus Inc.EOLSParschauer Karah Herdman
Director
23,458$023,458
(Direct)
View